Watchlist Price Alert

Fennec Pharmaceuticals In... (FENC)

NASDAQ: FENC · Real-Time Price · USD

7.68

-0.20 (-2.48%)

At close: Jun 04, 2025, 3:59 PM

7.67

-0.13%

After-hours: Jun 04, 2025, 04:04 PM EDT

Fennec Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	26.63M	13.27M	23.77M	21.1M	30.34M	13.65M	22.78M	28.26M	3.93M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	822K	6K	211K	27K	n/a	262K	n/a	n/a	n/a
Receivables	12.88M	8.81M	1.54M	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	1.06M	2.16M	576K	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	466K	44K	63K	253K	276K	8K	1K	13K	3K
Total Current Assets	44.12M	26.86M	26.73M	22.39M	31.42M	13.88M	22.95M	28.4M	3.97M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	822K	6K	211K	27K	n/a	262K	n/a	n/a	n/a
Total Assets	44.95M	26.86M	26.94M	22.41M	31.42M	14.15M	22.95M	28.4M	3.97M
Account Payables	2.88M	3.78M	2.39M	777K	1.57M	1.61M	1.03M	855K	244K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	616K	n/a	n/a	n/a	n/a	n/a	n/a	167K	33K
Total Current Liabilities	6.92M	7.55M	4.61M	1.65M	2.35M	2.27M	1.64M	1.64M	402K
Long-Term Debt	19.34M	30.93M	24.9M	4.99M	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	24.56M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	43.9M	30.93M	24.9M	4.99M	n/a	n/a	1.03M	855K	244K
Total Liabilities	50.82M	38.49M	29.51M	6.64M	2.35M	2.27M	1.64M	1.64M	402K
Total Debt	19.34M	30.95M	24.9M	4.99M	n/a	n/a	n/a	n/a	n/a
Common Stock	145.61M	144.31M	142.59M	140.8M	140.73M	106.39M	106.39M	103.05M	74.52M
Retained Earnings	-219.68M	-219.25M	-203.2M	-179.49M	-162.14M	-144.03M	-131.26M	-121.37M	-114.32M
Comprehensive Income	1.24M	1.24M	1.24M	1.24M	1.24M	1.24M	1.24M	1.24M	1.24M
Shareholders Equity	-5.51M	-11.62M	-2.57M	15.77M	29.07M	11.88M	21.31M	26.76M	3.57M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a